Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study

Abstract

Within some clinical scenarios, industry payments to physicians are associated with non-recommended and low value drugs. These findings raise quality of care concerns about the financial relationships between physicians and industry.